Memorial Hermann Health System

Over the past month, two large provider organizations have announced partnerships with Reimagine Care, a Nashville-based startup focused on providing support to cancer patients who are in active treatment. Moffitt Cancer Center in Tampa teamed up with Reimagine on Monday, and Memorial Hermann Health System, a 17-hospital system based in Houston, expanded its on-demand cancer care partnership with the startup a month ago. These partnerships seek to make cancer care more comfortable and accessible for patients. Reimagine, founded in 2020, serves as an “an extension of the cancer center,” said CEO Dan Nardi. The startup uses an AI virtual assistant named Remi, as well as its own nurses and advanced practice practitioners trained in clinical oncology, to provide on-demand virtual support for cancer patients. Sponsored Post Get Ready for HLTH 2024: A Preview Guide HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight new programming, a physicians roundtable, generative AI, the shifting landscapes of telemedicine, retail health, women's health, and lots more. By Stephanie Baum “Reimagine Care’s program helps manage symptoms, increase adherence to oral medications and provide nutritional and [social determinants of health] support, all with the look and feel of the patient’s primary oncology team,” Nardi stated. After a cancer patient gets enrolled in Reimagine’s program, they can interact with Remi or text the startup’s clinical oncology experts at any time of the day or night. By giving patients the option to quickly text a medical expert whenever they have a concern, Reimagine is seeking to identify symptoms earlier — which enables resolution before these concerns escalate and require a visit to the emergency department, Nardi pointed out. He added that Reimagine’s 24/7 texting offering not only addresses patients’ physical symptoms, but also fosters a sense of emotional wellbeing, as on-demand care helps patients feel heard and cared for. Nardi also declared that cancer care has a supply and demand problem. presented by Health IT Accelerating Claim Processing: Strategies to Shorten the Life of a Claim These strategies and practices can significantly shorten the life cycle of claims, leading to quicker resolutions and improved financial outcomes. By Greenway Health “Patients are being newly diagnosed at a higher rate than ever. People with cancer are living longer, and yet there aren’t enough clinicians to meet the complex and growing needs of these patients,” he said. More than 90% of oncologists report working outside normal hours to keep up with their patients’ needs, Nardi noted. Reimagine is trying to alleviate these pressures by decreasing work interruptions and improving symptom management while patients are at home, he stated. In his view, Reimagine extends the capacity of care teams, giving patients fast and personalized support without overwhelming the existing staff at their cancer center. When the startup began its partnership with Memorial Hermann during the summer of last year, its program was originally available only to patients with breast and sarcoma cancers. Memorial Hermann has now deepened the partnership, offering Reimagine’s program to patients with other solid tumor cancers and malignant hematology, Nardi said. Moffitt and Reimagine are currently working together to plan the program launch, which is slated for later this year. Nardi noted that this partnership will treat patients with all types of cancer. To measure the success of its partnerships, Reimagine tracks metrics related to patient engagement, patient satisfaction, emergency department avoidance and symptom resolution rates, he stated. Our partnership model brings revolutionary, on-demand care directly to the fingertips of patients in the most difficult part of their cancer journey – the treatment phase. By empowering them with the support, answers, and resources they need within minutes from the comfort and safety of their home, rather than hours or days in a clinic, we will collectively and drastically improve the experience of those touched by cancer,” Nardi remarked. In addition to Memorial Hermann and Moffitt, Reimagine also has partnerships with Colorado University and The Center for Cancer & Blood Disorders in Texas.

Midlife women’s health clinic Midi Health announced it has added a group of female investors to its oversubscribed $63 million Series B round via a $5 million Special Purpose Vehicle. New investors include actors and producers Amy Schumer and Connie Britton, soccer star Brandi Chastain, fashion designer/entrepreneur Tory Burch, Phenomenal Media’s Meena Harris, Sandberg Bernthal Venture Partners, investor and Angel City FC cofounder Kara Nortman. The venture fund run by former Meta COO Sheryl Sandberg and her husband Tom Bernthal, Waymo co-CEO Tekedra Mawakana, Stripe executive Claire Hughes Johnson, PagerDuty CEO Jennifer Tejada, and Toast CFO Elena Gomez also participated in the round. Other investors also joined, including executives from OpenAI, Apple, Amazon, Google, Meta, Atlassian, Databricks, Cloudflare, Warner Media, Universal Music Group, Life360 and Calm. The above group of capital investors joins the company's other Series B investors, including GV (Google Ventures), Emerson Collective, Memorial Hermann Health System, Black Angel Group, SemperVirens, Felicis, Icon Ventures, Ingeborg Investments, G9, Operator Collective and Gingerbread Capital. The company said that, in total, 80 investors participated in its Series B round. WHAT IT DOES The California-based company offers women 40 years of age and older a virtual care platform with access to nurse practitioners specializing in perimenopause and menopause. Physicians and researchers oversee the nurses. The platform provides interventions ranging from lifestyle coaching to prescription medication. "Just like you, I have noticed a clear gap in companies that prioritize the needs of women and address the challenges they face when seeking healthcare. Midi is breaking new ground for women 35+ as their healthcare needs evolve," Amy Schumer said in a statement. "The SPV investment opportunity was a unique way for leaders across different industries to come together to ensure women’s health remains at the forefront of innovation rather than as an afterthought as it has for so long. It’s important to invest in companies that impact us personally and be a force for change for women everywhere." MARKET SNAPSHOT Midi secured $60 million in its Series B funding round in April, bringing its total raise to $100 million. Last year, the company closed a $25 million Series A funding round led by Google Ventures and expanded access to its offerings in all 50 U.S. states, and in 2022, it scored a $14 million seed investment. Last month, the company announced a partnership with digital musculoskeletal care company Hinge Health to combine Hinge’s movement-based support with Midi's virtual care clinic to support women experiencing menopausal symptoms. In July, Midi collaborated with Keck Medicine of USC to provide personalized care plans to individuals going through perimenopause and menopause. Earlier this year, the company announced it was partnering with digital cognitive assessment company Neurotrack to help determine whether brain fog symptoms in women are indicative of menopause or signs of a severe cognitive impairment, such as early dementia. Last year, the company announced a partnership with Memorial Hermann Health System to provide virtual care services to Houston patients.

PALO ALTO, Calif.--( BUSINESS WIRE )--Hippocratic AI, the company building the first safety-focused Large Language Model (LLM) for healthcare, today announced it has received an investment from NVentures, NVIDIA’s venture capital arm in its recently closed extended Series A round. NVentures, along with Greycroft and Leo Shapiro of 7Wire Ventures, contributed a combined total of an additional $17 million to the round, bringing the total invested in the company to $137 million. The first close of the Series A round was co-led by Premji Invest and General Catalyst with participation from SV Angel and Memorial Hermann Health System as well as existing investors Andreessen Horowitz (a16z) Bio + Health, Cincinnati Children’s, WellSpan Health, and Universal Health Services (UHS) at a $500 million valuation. Hippocratic AI’s collaboration with NVIDIA is centered on cutting-edge technological advancements. Hippocratic AI is leveraging NVIDIA NIM microservices to scale its production platform to deliver low-latency and long-context conversational capabilities. The collaboration, launched at the NVIDIA GTC global AI conference earlier this year, includes several techniques tailored for real-time, long-context conversational AI, including prefix caching, speculative decoding, and prefill/decode disaggregation. In addition, Hippocratic AI, powered by NVIDIA technologies, is advancing medical domain specialization in LLMs through custom automated speech recognition (ASR) technology, fine-tuned to meet the needs of clinician-patient interactions. “ NVIDIA is an ideal collaborator to help us achieve our vision of delivering healthcare abundance,” said Munjal Shah, co-founder and CEO of Hippocratic AI. “ Our deep technical collaboration has helped us to build an LLM with extremely low latency leading to more empathetic inference capabilities. Their venture capital arm’s investment in our company demonstrates our shared interest in harnessing the power of generative AI to revolutionize healthcare.” “ Generative AI will expand the healthcare industry and its ability to serve the growing demands of patient care, and Hippocratic AI is putting the technology to work to increase access to healthcare,” said Kimberly Powell, vice president of healthcare at NVIDIA. “ The company’s safety-focused approach uses advanced NVIDIA technologies to make personalized, real-time patient interactions more natural and capable, helping build trust among patients and clinicians alike.” About Hippocratic AI Hippocratic AI’s mission is to develop the first safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google, and NVIDIA. Hippocratic AI has received a total of $137 million in funding and is backed by leading investors, including General Catalyst, Andreessen Horowitz, Premji Invest, SV Angel, NVentures, and Greycroft. For more information on Hippocratic AI: www.HippocraticAI.com .